|
[HAIC技术]
HAIC技术
日期:2022-02-13 22:13:20
点击:99
尽管标准化的HAIC技术是评估HAIC安全性和疗效的重要因素,但HAIC技术的异质性仍然是评价这一技术的争议之一。 许多HAI化疗技术可以通过放置一个输液港-导管系统来进行。 在过去,输液导管是通过剖腹手术植入的,但患者暴露于与剖腹手术和全身麻醉相关的风险。...
[HAIC单治疗]
HAIC
日期:2022-02-10 00:59:23
点击:99
简介 Hepatic artery infusion chemotherapy (HAIC) is a treatment modality for advanced hepatocellular carcinoma (HCC). 肝动脉输注化疗(HAIC)是治疗晚期肝癌(HCC)的一种治疗方式。 HAIC entails infusing chemotherapeutic agents directly into hepat...
[HAIC联合治疗]
基于HAIC的联合治疗
日期:2022-02-10 00:39:13
点击:99
The following characteristics of HAIC render it a suitable candidate for combination with other antineoplastic agents for advanced HCC: it is associated with fewer systemic adverse events compared with intravenous chemotherapy, and its cyt...
[缺乏进行试验的行业激励措施]
HAIC研究潜在障碍:缺乏行业激励
日期:2021-12-28 21:43:21
点击:99
Lack of Industry Incentive for Conducting Trials 开展试验缺乏行业激励 The patents for the main chemotherapeutic agents used in HAIC, including cisplatin, oxaliplatin, 5-FU, and epirubicin, have expired, thus weakening the motivation for th...
[缺乏技术标准]
HAIC研究潜在障碍:技术标准化不足
日期:2021-12-28 13:45:34
点击:99
Insufficient Technical Standardization Techniques and protocols for HAIC have yet to be standardized. HAIC的技术和方案尚未标准化。 The efficacy and safety of HAIC depend substantially on the quality of vascular redistribution. HAIC的有效性...
[重复导管 vs 动脉港]
HAIC研究潜在障碍:重复导管术 vs 药盒置入
日期:2021-12-28 13:34:36
点击:99
Two different percutaneous arterial access approaches have been used for HAIC: the first approach entails the use of implantable port-catheter systems, and the second approach involves repeated hepatic artery catheterization. 两种不同的经...
[多种化疗方案]
HAIC研究的潜在障碍:多种化疗方案
日期:2021-12-28 11:54:22
点击:99
A standard chemotherapy regimen for HAIC has yet to be established, increasing the challenge of interpreting trial results. HAIC的标准化疗方案尚未建立,这增加了解释试验结果的挑战。 Cisplatin and 5-FU were the most commonly used chemotherap...
[异质性患者数据]
HAIC研究潜在障碍:数据的异质性
日期:2021-12-27 15:27:25
点击:99
Studies on HAIC have included populations with various degrees of intrahepatic tumor burden, including the possible presence of PVT/EHS. 对HAIC的研究包括了不同程度肝内肿瘤负荷的人群,包括可能存在PVT/EHS。 Studies on patients with PVT who r...
[+ 免疫治疗]
HAIC 联合免疫治疗
日期:2021-12-27 08:50:24
点击:99
Immune checkpoint inhibitorbased combinations have changed the treatment paradigm for advanced HCC [59,60] and are likely to remain the cornerstone of systemic treatment in the next few years. 基于免疫检查点抑制剂的联合治疗已经改变了晚期HC...
[+ 放疗]
HAIC 联合放疗
日期:2021-12-25 11:25:23
点击:99
HAIC combined with radiation therapy (RT) has also been extensively investigated, particularly in subgroups of patients with PVT. HAIC联合放疗(RT)也已被广泛研究,特别是在PVT患者的亚组中。 Han et al. [ 51 ] conducted a small-scale single-ar...
男,69岁 - 代谢功能障碍肝硬化合并酒精性肝病(MetALD) - II型糖尿病,高血压 - Chi...
经导管动脉化疗性栓塞(Transcatheter arterial chemotherapy,TACE)是一种治疗肝脏...
单纯肝动脉栓塞的背景 Bland embolisation: Background 肝癌单纯栓塞(Bland emboliza...
超早期肝癌(0期)不能肝移植 消融(全身治疗辅助?)>5年生存如果失败或不可行TACE...
TACE术后病人的随访包括临床和影像 BCLC staging and treatment strategy, 2012 Forne...
栓塞治疗作为肿瘤治疗手段之一,被报道应用于全身多处部位的肿瘤。这其中包括肾癌、肺...